LARGE1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: The reduction in the amount of LARGE-dependent matriglycan result in heterogeneous forms of dystroglycanopathy that is associated with hypoglycosylation of αDG and a consequent lack of ligand-binding activity.